Research ArticleExperimental Studies

Effects of Medium Molecular Weight Heparinyl Phenylalanine on Type I Hypersensitivity

SEIICHI TAKEDA, TAKAO TODA and KAZUKI NAKAMURA
In Vivo January 2019, 33 (1) 53-55; DOI: https://doi.org/10.21873/invivo.11438

Article Information

vol. 33 no. 1 53-55
DOI 
https://doi.org/10.21873/invivo.11438
PMID 
30587602
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received October 10, 2018
  • Revision received October 22, 2018
  • Accepted October 23, 2018
  • Published online December 26, 2018.
Copyright & License 
Copyright © 2019 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. SEIICHI TAKEDA1⇑,
  2. TAKAO TODA1 and
  3. KAZUKI NAKAMURA2
  1. 1Research and Development Center, Fuso Pharmaceutical Industries Ltd, Osaka, Japan
  2. 2Department of Pharmacology I, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan
  1. Correspondence to: Dr. Seiichi Takeda, Research and Development Center, Fuso Pharmaceutical Industries LTD, 2-3-30, Morinomiya, Joto-ku, Osaka 536-8523, Japan. Tel: +81 669693131, Fax: +81 669642706, e-mail: sei-takeda{at}fuso-pharm.co.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Effects of Medium Molecular Weight Heparinyl Phenylalanine on Type I Hypersensitivity
SEIICHI TAKEDA, TAKAO TODA, KAZUKI NAKAMURA
In Vivo Jan 2019, 33 (1) 53-55; DOI: 10.21873/invivo.11438
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords